Intravenous Hydration Therapy Market
Description
IV Hydration Therapy Market Summary
The global intravenous hydration therapy market size was valued at USD 2.83 billion in 2025 and is projected to reach USD 5.66 billion by 2033, growing at a CAGR of 9.2% from 2026 to 2033. This growth is attributed to the rising prevalence of chronic diseases such as diabetes, cardiovascular disorders, autoimmune conditions, and cancer, the growing popularity of wellness and beauty treatments, and the increasing availability of intravenous (IV) hydration therapy clinics, as well as the ease of use associated with this therapy.
The increasing demand for IV hydration therapy is driven by the shift toward convenient, personalized wellness options that go beyond traditional clinical care. For instance, in August 2025, AquaPulse IV introduced mobile IV therapy services in Fredericksburg, Virginia. The service provides customized hydration and vitamin infusions directly to clients’ homes, workplaces, or events, administered by licensed medical professionals. Such development shows how IV therapy is becoming part of a lifestyle and preventive health approach, offering people quick recovery, energy boosts, and immune support in environments that fit their daily routines. These on-demand models highlight the rising focus on accessibility and patient-centered care in wellness services.
Growing consumer interest in preventive wellness, recovery solutions, and personalized care models is driving the expansion of the IV hydration therapy market. Beyond traditional hydration and nutrient replacement, providers are offering specialized services that support long-term health goals. For instance, in May 2025, Hydration Room introduced the NAD+ IV Membership with tiered dosing options aimed at enhancing brain health, energy, and longevity. By providing monthly access to clinically supervised NAD+ therapy in flexible doses, the program exemplifies a wider trend toward subscription-based, customized care that prioritizes consistency, convenience, and proactive health management. These innovations, along with the growth of mobile IV services and tech-enabled delivery models, are turning IV hydration therapy into a mainstream wellness option that serves both acute recovery and ongoing health optimization.
Global Intravenous Hydration Therapy Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global intravenous hydration therapymarket report based on service, component, provider, end-use, and region:
The global intravenous hydration therapy market size was valued at USD 2.83 billion in 2025 and is projected to reach USD 5.66 billion by 2033, growing at a CAGR of 9.2% from 2026 to 2033. This growth is attributed to the rising prevalence of chronic diseases such as diabetes, cardiovascular disorders, autoimmune conditions, and cancer, the growing popularity of wellness and beauty treatments, and the increasing availability of intravenous (IV) hydration therapy clinics, as well as the ease of use associated with this therapy.
The increasing demand for IV hydration therapy is driven by the shift toward convenient, personalized wellness options that go beyond traditional clinical care. For instance, in August 2025, AquaPulse IV introduced mobile IV therapy services in Fredericksburg, Virginia. The service provides customized hydration and vitamin infusions directly to clients’ homes, workplaces, or events, administered by licensed medical professionals. Such development shows how IV therapy is becoming part of a lifestyle and preventive health approach, offering people quick recovery, energy boosts, and immune support in environments that fit their daily routines. These on-demand models highlight the rising focus on accessibility and patient-centered care in wellness services.
Growing consumer interest in preventive wellness, recovery solutions, and personalized care models is driving the expansion of the IV hydration therapy market. Beyond traditional hydration and nutrient replacement, providers are offering specialized services that support long-term health goals. For instance, in May 2025, Hydration Room introduced the NAD+ IV Membership with tiered dosing options aimed at enhancing brain health, energy, and longevity. By providing monthly access to clinically supervised NAD+ therapy in flexible doses, the program exemplifies a wider trend toward subscription-based, customized care that prioritizes consistency, convenience, and proactive health management. These innovations, along with the growth of mobile IV services and tech-enabled delivery models, are turning IV hydration therapy into a mainstream wellness option that serves both acute recovery and ongoing health optimization.
Global Intravenous Hydration Therapy Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global intravenous hydration therapymarket report based on service, component, provider, end-use, and region:
- Service Outlook (Revenue, USD Million, 2021 - 2033)
- Immune Boosters
- Energy Boosters
- Hydration
- Beauty/ Aesthetics
- Detoxification
- Longevity/ Antiaging
- Performance/ Athletics
- Migraine & Pain Relief
- Stress/Sleep/Mood Support
- Flu/Stomach
- Others
- Component Outlook (Revenue, USD Million, 2021 - 2033)
- Medicated
- Non-medicated
- Provider Outlook (Revenue, USD Million, 2021 - 2033)
- Mobile Providers
- Physical Providers
- End-use Outlook (Revenue, USD Million, 2021 - 2033)
- Hospitals & Clinics
- Wellness Centers and Spas
- Home Healthcare
- Others
- Regional Outlook (Revenue, USD Million, 2021 - 2033)
- North America
- U.S.
- Canada
- Mexico
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Thailand
- Latin America
- Brazil
- Argentina
- Middle East and Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
- Kuwait
Table of Contents
190 Pages
- Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.1.1. Segment Definitions
- 1.2. Estimates and Forecast Timeline
- 1.3. Research Methodology
- 1.4. Information Procurement
- 1.4.1. Purchased Database
- 1.4.2. GVR’s Internal Database
- 1.4.3. Secondary Sources
- 1.4.4. Primary Research
- 1.4.5. Details of Primary Research
- 1.4.6. Research Assumption
- 1.5. Information or Data Analysis
- 1.5.1. Data Analysis Models
- 1.6. Market Formulation & Data Visualization
- 1.7. Model Details
- 1.7.1. Commodity Flow Analysis
- 1.8. Objectives
- 1.8.1. Objective - 1
- 1.8.2. Objective - 2
- 1.8.3. Objective - 3
- 1.9. List of Secondary Sources
- 1.10. List of Secondary Sources
- Chapter 2. Executive Summary
- 2.1. U.S. Independent Diagnostic Testing Facility Market
- 2.1.1. Market Snapshot
- 2.1.2. Segment Snapshot
- 2.1.2.1. Service segment outlook
- 2.1.3. Competitive Landscape Snapshot
- Chapter 3. Market Variables, Trends, & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related/Ancillary Market Outlook
- 3.2. Market Trends and Outlook
- 3.2.1. Market Dynamics
- 3.2.1.1. Market Driver Analysis
- 3.2.1.2. Market Restraint Analysis
- 3.2.1.3. Market Opportunities Analysis
- 3.2.1.4. Market Challenges Analysis
- 3.3. Regulatory Framework
- 3.4. Business Environment Analysis Tools
- 3.4.1. Industry Analysis - Porter’s Five Forces Analysis
- 3.4.1.1. Supplier power
- 3.4.1.2. Buyer power
- 3.4.1.3. Substitution threat
- 3.4.1.4. Threat of new entrant
- 3.4.1.5. Competitive rivalry
- 3.4.2. PESTEL Analysis
- Chapter 4. Service Business Analysis
- 4.1. U.S. Independent Diagnostic Testing Facility Market: Service Movement Analysis
- 4.2. U.S. Independent Diagnostic Testing Facility Market: Service Segment Dashboard
- 4.3. Service Movement & Market Share Analysis, 2025 & 2033
- 4.4. U.S. Independent Diagnostic Testing Facility Market Estimates & Forecast, by Service
- 4.5. Radiology/Imaging Services
- 4.5.1. Radiology/imaging services market, 2021 - 2033 (USD Million)
- 4.5.2. X-Ray
- 4.5.2.1. X-ray market, 2021 - 2033 (USD Million)
- 4.5.3. Computed Tomography (CT)
- 4.5.3.1. Computed tomography (CT) market, 2021 - 2033 (USD Million)
- 4.5.4. Magnetic Resonance Angiography (MRA)
- 4.5.4.1. Magnetic resonance angiography (MRA) market, 2021 - 2033 (USD Million)
- 4.5.5. Magnetic Resonance Imaging (MRI)
- 4.5.5.1. Magnetic resonance imaging (MRI) market, 2021 - 2033 (USD Million)
- 4.5.6. Mammography
- 4.5.6.1. Mammography market, 2021 - 2033 (USD Million)
- 4.5.7. Ultrasound
- 4.5.7.1. Ultrasound market, 2021 - 2033 (USD Million)
- 4.5.8. Position Emission Tomography (PET) Scan
- 4.5.8.1. Position emission tomography (PET) scan market, 2021 - 2033 (USD Million)
- 4.6. Sleep Studies
- 4.6.1. Sleep studies market, 2021 - 2033 (USD Million)
- 4.7. Cardiac Monitoring Services
- 4.7.1. Cardiac monitoring services market, 2021 - 2033 (USD Million)
- Chapter 5. Company Landscape
- 5.1. Company Categorization
- 5.2. Company Market Position Analysis, 2025
- 5.3. Strategy Mapping
- 5.4. Company Profiles/Listing
- 5.4.1. RadNet, Inc.
- 5.4.1.1. Overview
- 5.4.1.2. Financial performance
- 5.4.1.3. Service benchmarking
- 5.4.1.4. Strategic initiatives
- 5.4.2. Vitalistics
- 5.4.2.1. Overview
- 5.4.2.2. Financial performance
- 5.4.2.3. Service benchmarking
- 5.4.2.4. Strategic initiatives
- 5.4.3. Breathe
- 5.4.3.1. Overview
- 5.4.3.2. Financial performance
- 5.4.3.3. Service benchmarking
- 5.4.3.4. Strategic initiatives
- 5.4.4. Texas MRI
- 5.4.4.1. Overview
- 5.4.4.2. Financial performance
- 5.4.4.3. Service benchmarking
- 5.4.4.4. Strategic initiatives
- 5.4.5. The Brookwood Diagnostic Center
- 5.4.5.1. Overview
- 5.4.5.2. Financial performance
- 5.4.5.3. Service benchmarking
- 5.4.5.4. Strategic initiatives
- 5.4.6. ACS Diagnostics, Inc.
- 5.4.6.1. Overview
- 5.4.6.2. Financial performance
- 5.4.6.3. Service benchmarking
- 5.4.6.4. Strategic initiatives
- 5.4.7. Houston MRI & Diagnostic Imaging
- 5.4.7.1. Overview
- 5.4.7.2. Financial performance
- 5.4.7.3. Service benchmarking
- 5.4.7.4. Strategic initiatives
- 5.4.8. TestSmarter Inc.
- 5.4.8.1. Overview
- 5.4.8.2. Financial performance
- 5.4.8.3. Service benchmarking
- 5.4.8.4. Strategic initiatives
- 5.4.9. Duke University and Duke University Health System
- 5.4.9.1. Overview
- 5.4.9.2. Financial performance
- 5.4.9.3. Service benchmarking
- 5.4.9.4. Strategic initiatives
- 5.4.10. Covenant Health Diagnostics
- 5.4.10.1. Overview
- 5.4.10.2. Financial performance
- 5.4.10.3. Service benchmarking
- 5.4.10.4. Strategic initiatives
- 5.4.11. AliveCor, Inc.
- 5.4.11.1. Overview
- 5.4.11.2. Financial performance
- 5.4.11.3. Service benchmarking
- 5.4.11.4. Strategic initiatives
- 5.4.12. Advanced Cardio Services
- 5.4.12.1. Overview
- 5.4.12.2. Financial performance
- 5.4.12.3. Service benchmarking
- 5.4.12.4. Strategic initiatives
- 5.4.13. Diagnostic Medical Testing Inc.
- 5.4.13.1. Overview
- 5.4.13.2. Financial performance
- 5.4.13.3. Service benchmarking
- 5.4.13.4. Strategic initiatives
- 5.4.14. K & T Diagnostic, Inc.
- 5.4.14.1. Overview
- 5.4.14.2. Financial performance
- 5.4.14.3. Service benchmarking
- 5.4.14.4. Strategic initiatives
- 5.4.15. Vestavia Diagnostic Center (VDC)
- 5.4.15.1. Overview
- 5.4.15.2. Financial performance
- 5.4.15.3. Service benchmarking
- 5.4.15.4. Strategic initiatives
- 5.4.16. Advanced Imaging Center
- 5.4.16.1. Overview
- 5.4.16.2. Financial performance
- 5.4.16.3. Service benchmarking
- 5.4.16.4. Strategic initiatives
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.


